Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
Veterinary Specialty Hospital, North County, San Marcos, California, USA.
Vet Surg. 2021 Jul;50 Suppl 1:O108-O115. doi: 10.1111/vsu.13675. Epub 2021 Jul 7.
To describe the perioperative characteristics and outcomes in dogs that underwent transperitoneal laparoscopic ureteronephrectomy (TLU) for primary renal neoplasia.
Short case series.
Seven client-owned dogs.
Medical records were reviewed and data extracted regarding perioperative characteristics and animal outcomes. TLU was performed using a single-port + 1 or multiple port techniques. Hemostatic clips or a vessel-sealing device were used for occlusion of renal hilar vessels. The ureter was occluded and transected close to the ureterovesicular junction and the tumor was placed in a specimen retrieval bag for extraction from the abdomen.
Preoperative contrast enhanced computed tomography (CECT) was performed in 6/7 dogs. Median estimated tumor volume measured from abdominal CECT removed by TLU was 32.42 cm (interquartile range [IQR] 14.76-94.85). Median surgery time for TLU was 90 minutes (IQR 85-105). In one dog, elective conversion to open laparotomy was performed due to large tumor size. Median time to discharge was 31 hours (IQR 24-48). No major perioperative complications occurred and all dogs survived to discharge. Progression free survival in four dogs was 422 days (IQR 119-784).
TLU was performed for the extirpation of modest sized primary renal tumors with acceptable perioperative outcomes and a low complication rate.
TLU may be considered for the treatment of selected cases of primary renal neoplasia in dogs.
描述经腹腔腹腔镜输尿管切除术(TLU)治疗原发性肾肿瘤的围手术期特点和结果。
短篇病例系列。
7 只患犬。
回顾了病历并提取了围手术期特征和动物结果的数据。TLU 采用单端口+1 个或多个端口技术进行。使用止血夹或血管密封装置夹闭肾门血管。输尿管靠近输尿管膀胱连接部结扎和切断,肿瘤放入标本回收袋中从腹部取出。
6/7 只犬术前进行了增强 CT(CECT)检查。TLU 切除的腹部 CECT 测量的肿瘤体积中位数为 32.42cm3(四分位距[IQR] 14.76-94.85)。TLU 的中位手术时间为 90 分钟(IQR 85-105)。由于肿瘤体积大,一只犬择期转为开腹手术。中位出院时间为 31 小时(IQR 24-48)。无重大围手术期并发症,所有犬均存活至出院。4 只犬的无进展生存时间为 422 天(IQR 119-784)。
TLU 可用于切除大小适中的原发性肾肿瘤,具有可接受的围手术期结果和低并发症发生率。
TLU 可考虑用于治疗犬的某些原发性肾肿瘤病例。